- $1.08bn
- $1.20bn
- $3.79bn
- 96
- 94
- 67
- 98
Annual income statement for Scansource, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,250 | 3,048 | 3,151 | 3,530 | 3,788 |
| Cost of Revenue | |||||
| Gross Profit | 393 | 356 | 351 | 427 | 449 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,155 | 3,113 | 3,089 | 3,408 | 3,652 |
| Operating Profit | 94.7 | -65 | 61.5 | 122 | 136 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 83.6 | -71.8 | 57.5 | 119 | 122 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 64 | -79.2 | 45.4 | 88.7 | 88.1 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 57.6 | -193 | 10.8 | 88.8 | 89.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 57.6 | -193 | 10.8 | 88.8 | 89.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.52 | 2.23 | 2.59 | 3.44 | 3.65 |